Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ADAPTHEALTH CORP.

(AHCO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

AdaptHealth Corp.(NasdaqCM:AHCO) added to Russell 3000 Value Index

06/25/2021 | 12:00am EDT

AdaptHealth Corp.(NasdaqCM:AHCO) added to Russell 3000 Value Index


© S&P Capital IQ 2021
All news about ADAPTHEALTH CORP.
10/04ADAPTHEALTH : ANNOUNCES APPOINTMENT OF GREG BELINFANTI AS DIRECTOR (Form 8-K)
PU
09/30AdaptHealth Corp. Announces Appointment of Greg Belinfanti as Director
CI
08/30AdaptHealth Corp. Announces Resignation of Alan Quasha from the Board, Effective Septem..
CI
08/13DFB HEALTHCARE ACQUISITIONS : AdaptHealth Prices Upsized $600 Million 5.125% Senior Notes ..
MT
08/11ADAPTHEALTH : Announces Proposed Offering of $550 Million Senior Notes Due 2030 (Form 8-K)
PU
08/05SECTOR UPDATE : Health Care Stocks Trim Losses Late
MT
08/05SECTOR UPDATE : Health Care Stocks Sliding Thursday While Biotechs Advance
MT
08/05DFB HEALTHCARE ACQUISITIONS : AdaptHealth Reports Earnings, Revenue Increase for Q2, Raise..
MT
08/05AdaptHealth Corp. Increases Earnings Guidance for the Fiscal Year 2021
CI
08/05AdaptHealth Corp. Reports Unaudited Consolidated Earnings Results for the Second Quarte..
CI
More news
Financials (USD)
Sales 2021 2 413 M - -
Net income 2021 130 M - -
Net Debt 2021 1 770 M - -
P/E ratio 2021 27,0x
Yield 2021 -
Capitalization 3 377 M 3 377 M -
EV / Sales 2021 2,13x
EV / Sales 2022 1,84x
Nbr of Employees 4 700
Free-Float 61,7%
Chart ADAPTHEALTH CORP.
Duration : Period :
AdaptHealth Corp. Technical Analysis Chart | AHCO | US00653Q1022 | MarketScreener
Technical analysis trends ADAPTHEALTH CORP.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 25,80 $
Average target price 38,90 $
Spread / Average Target 50,8%
EPS Revisions
Managers and Directors
Stephen P. Griggs Chief Executive Officer & Director
Joshua Parnes President & Director
Jason A. Clemens Chief Financial Officer
Richard A. Barasch Chairman
Albert A. Prast Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
ADAPTHEALTH CORP.-31.31%3 377
ABBOTT LABORATORIES14.21%221 691
MEDTRONIC PLC3.85%163 718
BECTON, DICKINSON AND COMPANY-1.50%70 784
HOYA CORPORATION19.13%55 133
DEXCOM, INC.53.66%54 963